Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The deubiquitinating enzyme 3 pseudogene (ENSG00000254923; LOC392196) is a non-protein-coding sequence in the human genome, bearing similarity to deubiquitinating enzymes but lacking enzymatic activity or established biological function[5]. Deubiquitinating enzymes (DUBs) are a family of proteases that remove ubiquitin from proteins and have major roles in regulating protein degradation, cell signaling, DNA repair, and epigenetic modification[1][2][4]. However, pseudogenes such as this one do not code for a functional enzyme and thus do not carry out these molecular functions nor serve as current therapeutic targets. The naming of this pseudogene reflects historical sequence similarity to active DUB gene family members (such as ubiquitin C-terminal hydrolases or ubiquitin-specific peptidases) but should not be confused with functional proteins of the DUB superfamily[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deubiquitinating enzyme 3 pseudogene.